Login / Signup
Another step toward frontline BTK inhibitor therapy in MCL.
Walter Hanel
Narendranath Epperla
Published in:
Blood advances (2023)
Keyphrases
</>
tyrosine kinase
stem cells
bone marrow
cell therapy